Editor’s note: This is a developing story. Please check back soon for updates.Under the terms of a definitive agreement, Biogen will acquire Apellis for $41 per share in cash, or approximately $5.6 billion, according to a press release from Biogen.The …
A subcutaneous monoclonal antibody induced greater reductions in proptosis at 24 weeks than placebo for people with active thyroid eye disease, according to topline results from the REVEAL-1 trial.Elegrobart (Viridian Therapeutics) is a half-life exten…
A subcutaneous monoclonal antibody induced greater reductions in proptosis at 24 weeks than placebo for people with active thyroid eye disease, according to topline results from the REVEAL-1 trial.Elegrobart (Viridian Therapeutics) is a half-life exten…
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation, the full-stack neural engineering and brain-computer interface (BCI) company focused on restoring and extending life, today announced the appointment of Murat Günel, MD, as Medical Director for Bra…
ATHERTON, Calif.–(BUSINESS WIRE)–Amaros Launches Interventional Glaucoma Network to Advance Evidence in Interventional Glaucoma
ATHERTON, Calif.–(BUSINESS WIRE)–Amaros Launches Interventional Glaucoma Network to Advance Evidence in Interventional Glaucoma